Jeff Geschwind, MD: Visionary in Cancer Innovation Jeff Geschwind, MD, combines drug development, imaging tech, and interventional therapies to redefine cancer care. His multidisciplinary approach positions him as a leader in modern oncology. https://www.onclive.com/authors/jeff-geschwind-md-johns-hopkins